Formula: | C17H22F2N4O3S2 |
Molecular Weight: | 432.52 |
Rotatable Bond Donors: | 5 |
clogP: | 2.49 |
Topological Polar Surface Area: | 119.38 |
Lipinski's RO5: | MW: 432.52 HBA: 7 HBD: 4 RB: 5 LogP: 2.49 |
Rule of Three: | MW: 432.52 HBA: 7 HBD: 4 RB: 5 LogP: 2.49 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC140942397 | 1.0 | ZINC140942397 RDKit 3D 28 30 0 0 0 0 0 0 0 0999 V2000 -4.2923 2.9841 -1.8352 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3262 2.2640 -0.9248 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6189 1.1262 -1.6348 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5460 0.2732 -2.1510 F 0 0 0 0 0 0 0 0 0 0 0 0 -1.9680 1.6450 -2.7176 F 0 0 0 0 0 0 0 0 0 0 0 0 -1.6854 0.4339 -0.6780 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3090 0.5804 -0.8932 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6384 -0.0370 -0.0805 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0030 0.1870 -0.3192 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3323 0.3495 -1.7258 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8307 0.4260 -1.9271 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5650 0.7682 -0.6466 C 0 0 0 0 0 0 0 0 0 0 0 0 6.3097 0.8323 -0.9545 S 0 0 0 0 0 0 0 0 0 0 0 0 6.9458 1.4726 0.5734 C 0 0 0 0 0 0 0 0 0 0 0 0 6.5452 1.8332 -1.9761 O 0 0 0 0 0 0 0 0 0 0 0 0 6.7955 -0.5253 -1.1041 O 0 0 0 0 0 0 0 0 0 0 0 0 4.2596 -0.2175 0.4659 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8422 -0.7457 0.4109 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2777 -0.7877 0.9721 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0450 -0.9267 1.1746 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5969 -1.8738 2.4729 S 0 0 0 0 0 0 0 0 0 0 0 0 -3.2421 -1.5743 2.0973 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3232 -2.1368 2.8990 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9335 -2.9773 3.9240 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.5137 -1.8957 2.6996 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.3420 -0.7568 0.9846 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.5295 -0.3528 0.4682 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.0735 -0.3683 0.4258 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 3 5 1 0 3 6 1 0 6 7 2 0 7 8 1 0 8 9 1 0 9 10 1 0 10 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 13 15 2 0 13 16 2 0 12 17 1 0 17 18 1 0 8 19 2 0 19 20 1 0 20 21 1 0 21 22 1 0 22 23 1 0 23 24 1 0 23 25 2 0 22 26 2 0 26 27 1 0 26 28 1 0 28 6 1 0 18 9 1 0 28 20 2 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |